| Date Filed | Type | Description |
| 10/10/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Bought 58,839 shares
@ $59.8973, valued at
$3.5M
|
|
| 10/04/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Bought 74,911 shares
@ $57.37, valued at
$4.3M
Bought 150,487 shares
@ $57.252, valued at
$8.6M
Bought 67,814 shares
@ $57.3188, valued at
$3.9M
|
|
| 10/03/2023 |
4
| Sturge Simon (Director) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Converted 342,980 shares
@ $0
Disposed/sold 342,980 shares
@ $0
Converted 10,196 options to buy
@ $0 |
|
| 10/03/2023 |
4
| Bodenstedt Matthias (CFO) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Converted 62,972 shares
@ $0
Disposed/sold 62,972 shares
@ $0
Converted 1,872 options to buy
@ $0 |
|
| 10/03/2023 |
4
| Santos da Silva Jorge (CEO) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Converted 3,027,483 shares
@ $0
Disposed/sold 3,027,483 shares
@ $0
Converted 140,071 shares
@ $0
Disposed/sold 140,071 shares
@ $0
Converted 90,000 options to buy
@ $0
Converted 4,164 options to buy
@ $0 |
|
| 10/03/2023 |
4
| Reich Kristian (Chief Scientific Officer) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Converted 2,527,477 shares
@ $0
Disposed/sold 2,527,477 shares
@ $0
Converted 41,981 shares
@ $0
Disposed/sold 41,981 shares
@ $0
Converted 75,136 options to buy
@ $0
Converted 1,248 options to buy
@ $0 |
|
| 07/05/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Bought 800,000 shares
@ $50, valued at
$40M
|
|
| 06/28/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Bought 1,481 shares
@ $36.91, valued at
$54.7k
Bought 3,755 shares
@ $38.18, valued at
$143.4k
Bought 10,593 shares
@ $39.17, valued at
$414.9k
Bought 38,623 shares
@ $39.87, valued at
$1.5M
Bought 50,642 shares
@ $41.03, valued at
$2.1M
Bought 61,042 shares
@ $42.12, valued at
$2.6M
Bought 66,087 shares
@ $43.3, valued at
$2.9M
Bought 31,558 shares
@ $44.23, valued at
$1.4M
Bought 10,946 shares
@ $44.93, valued at
$491.8k
Bought 37,783 shares
@ $48.93, valued at
$1.8M
Bought 59,787 shares
@ $49.82, valued at
$3M
|
|
| 06/12/2023 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Granted 11,297 options to buy
@ $29.18, valued at
$329.6k
|
|
| 06/12/2023 |
4
| Sturge Simon (Director) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Granted 11,297 options to buy
@ $29.18, valued at
$329.6k
|
|
| 06/12/2023 |
4
| Xavier Ramnik (Director) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Granted 11,297 options to buy
@ $29.18, valued at
$329.6k
|
|
| 06/12/2023 |
4
| Loy Spike (Director) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Granted 11,297 options to buy
@ $29.18, valued at
$329.6k
|
|
| 06/12/2023 |
4
| Moukheibir Catherine (Director) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Granted 11,297 options to buy
@ $29.18, valued at
$329.6k
|
|
| 06/12/2023 |
4
| Phillips Andrew John (Director) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Granted 11,297 options to buy
@ $29.18, valued at
$329.6k
|
|
| 03/22/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Bought 446,881 shares
@ $19.3639, valued at
$8.7M
Bought 63,700 shares
@ $20.4207, valued at
$1.3M
Bought 78,008 shares
@ $21.0836, valued at
$1.6M
Bought 238,511 shares
@ $21.7013, valued at
$5.2M
|
|
| 05/05/2022 |
4
| Sturge Simon (Director) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Granted 45,000 options to buy
@ $12.25, valued at
$551.3k
|
|
| 05/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/15/2022 |
3
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 3 on MoonLake Immunotherapeutics |
| 04/15/2022 |
3
| Reich Kristian (Chief Scientific Officer) has filed a Form 3 on MoonLake Immunotherapeutics |
| 04/15/2022 |
3
| Santos da Silva Jorge (CEO) has filed a Form 3 on MoonLake Immunotherapeutics |
| 04/15/2022 |
3
| Sturge Simon (Director) has filed a Form 3 on MoonLake Immunotherapeutics |
| 04/15/2022 |
3
| Phillips Andrew John (Director) has filed a Form 3 on MoonLake Immunotherapeutics |
| 04/15/2022 |
3
| Bodenstedt Matthias (CFO) has filed a Form 3 on MoonLake Immunotherapeutics |
| 04/15/2022 |
3
| Lassen Kara (Director) has filed a Form 3 on MoonLake Immunotherapeutics |
| 04/15/2022 |
3
| Xavier Ramnik (Director) has filed a Form 3 on MoonLake Immunotherapeutics |
| 04/15/2022 |
3
| Loy Spike (Director) has filed a Form 3 on MoonLake Immunotherapeutics |
| 04/15/2022 |
3
| Moukheibir Catherine (Director) has filed a Form 3 on MoonLake Immunotherapeutics |
| 04/07/2022 |
4
| Helix Holdings LLC (Former 10% Holder) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Converted 2,785,000 shares
@ $0
Converted 2,785,000 options to buy
@ $0 |
|
| 04/07/2022 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Converted 2,785,000 shares
@ $0
Bought 2,850,000 shares
@ $10, valued at
$28.5M
Converted 2,785,000 options to buy
@ $0 |
|
| 10/22/2020 |
4
| Chen Bihua (CEO and Chairman) has filed a Form 4 on Helix Acquisition Corp|
Txns:
| Bought 430,000 shares
@ $10, valued at
$4.3M
|
|
| 10/22/2020 |
4
| Helix Holdings LLC (10% Owner) has filed a Form 4 on Helix Acquisition Corp|
Txns:
| Bought 430,000 shares
@ $10, valued at
$4.3M
|
|
| 10/19/2020 |
3
| Chen Bihua (CEO and Chairman) has filed a Form 3 on Helix Acquisition Corp |
|